Cargando…

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way

Detalles Bibliográficos
Autores principales:	Chaves, Otávio Augusto, Sacramento, Carolina Q, Fintelman-Rodrigues, Natalia, Temerozo, Jairo Ramos, Pereira-Dutra, Filipe, Mizurini, Daniella M, Monteiro, Robson Q, Vazquez, Leonardo, Bozza, Patricia T, Castro-Faria-Neto, Hugo Caire, Souza, Thiago Moreno L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492308/ https://www.ncbi.nlm.nih.gov/pubmed/35759391 http://dx.doi.org/10.1093/jmcb/mjac039

Ejemplares similares

Fluorine Atoms on C(6)H(5)-Corrole Affect the Interaction with M(pro) and PL(pro) Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
por: Chaves, Otávio Augusto, et al.
Publicado: (2022)

Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 M(pro), Impairing Variants Replication In Vitro and In Vivo
por: Chaves, Otávio Augusto, et al.
Publicado: (2021)

Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
por: Mizurini, Daniella M., et al.
Publicado: (2021)

Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
por: Wang, Xuanting, et al.
Publicado: (2021)

Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
por: Wang, Xuanting, et al.
Publicado: (2022)

HIV-1 and Its gp120 Inhibits the Influenza A(H1N1)pdm09 Life Cycle in an IFITM3-Dependent Fashion
por: Mesquita, Milene, et al.
Publicado: (2014)

In Vitro Mode of Action and Anti-thrombotic Activity of Boophilin, a Multifunctional Kunitz Protease Inhibitor from the Midgut of a Tick Vector of Babesiosis, Rhipicephalus microplus
por: Assumpção, Teresa C., et al.
Publicado: (2016)

Salivary Thromboxane A2-Binding Proteins from Triatomine Vectors of Chagas Disease Inhibit Platelet-Mediated Neutrophil Extracellular Traps (NETs) Formation and Arterial Thrombosis
por: Mizurini, Daniella M., et al.
Publicado: (2015)

Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation
por: Soares, Vinicius Cardoso, et al.
Publicado: (2023)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Aftermath of Apixaban: Atypical Anticoagulation Aftereffect
por: Karki, Bhesh, et al.
Publicado: (2022)

Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
por: Sacramento, Carolina Q., et al.
Publicado: (2022)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Pituitary Apoplexy in the Setting of Oral Anticoagulation Therapy With Apixaban
por: Rivera-Nieves, Yadiel, et al.
Publicado: (2021)

Spontaneous thoracolumbar epidural hematoma in an apixaban anticoagulated patient
por: Theofanopoulos, Andreas, et al.
Publicado: (2021)

Dual Anticoagulation With Warfarin and Apixaban: A Case Report
por: Parker, Kristen, et al.
Publicado: (2022)

An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy
por: Shaw, Dylan J, et al.
Publicado: (2023)

Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19
por: Hottz, Eugenio D., et al.
Publicado: (2022)

Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
por: Teixeira, Lívia, et al.
Publicado: (2022)

Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2020)

Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin
por: Jablonka, Willy, et al.
Publicado: (2015)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)

Anticoagulant activity of apixaban can be estimated by multiple regression analysis
por: Unami, Naoko, et al.
Publicado: (2020)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
por: Ferreira, André C., et al.
Publicado: (2021)

Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects?
por: Freyburger, Geneviève, et al.
Publicado: (2015)

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018)

Sustained resolution of anticoagulation related iron deficiency anemia with the use of apixaban
por: Choo, Alex, et al.
Publicado: (2019)

Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Úlehlová, Jana, et al.
Publicado: (2021)

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
por: Ansell, Jack, et al.
Publicado: (2021)

Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages
por: Ferreira, André C., et al.
Publicado: (2023)

Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography
por: Artang, Ramin, et al.
Publicado: (2021)

Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban
por: Farooqui, Azhar, et al.
Publicado: (2022)

SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
por: Lechuga, Guilherme C., et al.
Publicado: (2021)

Massive Spontaneous Hemothorax as a Complication of Apixaban Treatment
por: Abu Hishmeh, M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0oiek6gmvshnsu0lnrl6poa7a5